Information  X 
Enter a valid email address

Byotrol PLC (BYOT)

  Print          Annual reports

Monday 21 June, 2021

Byotrol PLC

Alcohol-free Hand Sanitisers Backed by TIGGR

RNS Number : 5139C
Byotrol PLC
21 June 2021
 

 

 

B y otrol Plc

( " B y o t rol" or the "Company")

 

 

Alcohol-free hand sanitisers

backed by UK Taskforce on Innovation, Growth and Regulatory Reform ("TIGRR") 

 

 

 

Byotrol plc (AIM:BYOT) the specialist infection prevention and control company, is pleased to note new recommendations relating to support for alcohol-free hand sanitisers, set out in the recent UK government-sponsored TIGRR report on the UK regulatory regime post Brexit, and published by the Prime Minister's Office.

 

The recommendations, once implemented, will formally put alcohol-free hand sanitisers on a level PR and regulatory playing-field with alcohol-based products, and will:

 

· address confusion amongst consumers, healthcare professionals and business users about what is and what is not effective against bacteria and viruses such as coronavirus

· provide support for effective alternative products, including to those people with skin-sensitivity or cultural, health or safety concerns relating to alcohol-based sanitisers

· increase consumer choice, promote broader compliance and in turn promote public health

 

 

The recommendations can be found at (Proposal 17.5):

 

Taskforce on Innovation, Growth and Regulatory Reform independent report - GOV.UK (www.gov.uk)

 

Byotrol's alcohol-free, anti-viral 'Invirtu' hand sanitiser is formulated to pass all necessary test protocols and is already available in UK retail as Boots Anti-Viral Hand Foam, and in numerous NHS and UK workplaces under a variety of well-known professional brands.

 

 

Trevor Francis, Chief Technology Officer of Byotrol plc commented :

 

"Many chemistries other than alcohol are effective against viruses and bacteria and indeed many are already being used by healthcare professionals, including surgeons.  But alcohol-based products seem to date to have been - we believe incorrectly - favoured in advice from public agencies.

 

This new report shows a very welcome pathway to creating a level-playing field for alternative efficacious hand sanitisers in the UK, so promoting consumer choice and public health."

 

 

Enquiries:

 

Byotrol plc 

Trevor Francis - Chief Technology Officer

David Traynor - Chief Executive Officer

Nic Hellyer - Chief Financial Officer  01925 742 000

 

finnCap

Geoff Nash/Kate Bannatyne - Corporate Finance    020 7220 0500

Richard Chambers - ECM

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon   +44 (0)207 129 1474

[email protected]

 

 

 

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.

 

Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.

 

Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to byotrol.co.uk

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGSGDLXUDDGBB

a d v e r t i s e m e n t